2 results match your criteria: "Angiogenesis and Wound Healing Center[Affiliation]"
Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab.
JAAD Case Rep
March 2017
Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Angiogenesis and Wound Healing Center, Brigham and Women's Hospital, Boston, Massachusetts.
Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with infliximab: report of a case.
Arch Dermatol
April 2009
Department of Dermatology, Angiogenesis and Wound Healing Center, 221 Longwood Ave, Boston, MA 02115, USA.
Background: Necrobiosis lipoidica diabeticorum (NLD) is a rare, granulomatous inflammatory skin disease of unknown origin, sometimes associated with diabetes mellitus. Skin lesions usually develop on the lower extremities and can progress toward ulceration and scarring. Many treatments have been proposed, but few have demonstrated consistent efficacy, and no standard regimens have emerged to date.
View Article and Find Full Text PDF